Clinical Study

Cardiovascular Autonomic Neuropathy in Context of Other Complications of Type 2 Diabetes Mellitus

Table 4

Multivariate logistic regression analysis.

Odds ratio95% CIP value

Model 1
 Male/female1.800.55 to 5.840.32
 Age (years)1.481.21 to 2.12<0.0001
 Diabetes duration (years)1.741.46 to 2.07<0.0001
Model 2
 Cholesterol (mg%)1.0091.0007 to 1.01820.03
 Triglycerides (mg%)0.990.9963 to 1.00220.61
 HbA1c1.881.3101 to 2.72020.0007
 FPG (mg%)0.990.9899 to 1.00410.40
Model 3
 Retinopathy (yes versus no)4.140.3942 to 43.67950.23
 Peripheral neuropathy (yes versus no)15.475.1626 to 46.3864<0.0001
 IMT17.840.3795 to 838.93390.14
 QTC1.031.0074 to 1.05810.01
 ABI0.290.0052 to 16.24280.54
Model 4
 Smoking (yes versus no)2.211.0859 to 4.53070.02
 Body mass index (kg/m2) 1.121.0530 to 1.21000.0006
 HT1.430.6713 to 3.07470.35

HbA1c: glycosylated hemoglobin, FPG: fasting plasma glucose, IMT: intima-media thickness, QTC: corrected QT interval, ABI: ankle-brachial index, and HT: hypertension.